Rheumatology NewsFDA grants emergency authorization for Novavax COVID vaccineJuly 14, 2022COVID-19 Updates
Rheumatology NewsFDA adds RA indication for Riabni rituximab biosimilarJune 8, 2022Rheumatoid Arthritis
Rheumatology NewsFDA authorizes Pfizer’s COVID booster for kids ages 5 to 11May 18, 2022COVID-19 Updates
Rheumatology NewsUpadacitinib earns FDA approval for ankylosing spondylitis May 2, 2022Ankylosing spondylitisPsoriatic ArthritisRheumatoid ArthritisSpondyloarthropathies
Rheumatology NewsAs FDA OKs another COVID booster, some experts question needMarch 29, 2022COVID-19 Updates
Rheumatology NewsImmunocompromised patients should receive fourth COVID shot: CDCJanuary 28, 2022COVID-19 Updates
Rheumatology NewsFDA approves risankizumab (Skyrizi) for psoriatic arthritisJanuary 27, 2022Psoriatic Arthritis
Rheumatology NewsCDC to update mask recommendations as Omicron spreadsJanuary 13, 2022COVID-19 Updates
Rheumatology NewsCDC defends new COVID guidance as doctors raise concernsJanuary 5, 2022COVID-19 Updates
Rheumatology NewsCOVID-19 antigen tests may be less sensitive to Omicron: FDADecember 30, 2021COVID-19 Updates
